glp-1/gip dual agonist mechanism of action Main physiological actions the GIP and GLP-1 The Emerging Role of Dual

This mini review explores the increasing prevalence of obesity in type 1 diabetes (T1D) and the challenges patients face in achieving optimal glycemic contro...

This review summarizes current evidence on the nutritional implications of GLP1-based pharmacotherapy in adults with obesity, including common gastrointestinal adverse events, reduced energy intake, potential macro and micronutrient inadequacies, and risks of lean mass loss

Here, we report three cryo-electron microscopy structures of GLP-1R bound to (i) compound 2 (an ago-allosteric modulator)

Here, we provide a comprehensive review of the therapeutic potential of incretin mimetics and insulin in AD and PD.